...
首页> 外文期刊>International surgery >Significance of hepatic lymph node metastasis in patients with unresectable synchronous liver metastasis of colorectal cancer.
【24h】

Significance of hepatic lymph node metastasis in patients with unresectable synchronous liver metastasis of colorectal cancer.

机译:不可切除的大肠癌同步肝转移患者肝淋巴结转移的意义。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The frequency and significance of hepatic lymph node (HLN) metastasis were retrospectively evaluated in 43 patients with unresectable synchronous liver metastasis of colorectal cancer who underwent resection of the primary tumor and histopathologic evaluation of HLNs between March 1997 and August 2007. HLN metastasis was detected in 12 patients (27.9%). No significant correlations were observed between the presence of HLN metastasis and any of the 12 clinicopathologic factors examined. On multivariate analysis using the Cox proportional hazards model, the presence of HLN metastasis (P = 0.002), along with a large number (> or = 4) of regional lymph node metastases (P = 0.003), and nonuse of oxaliplatin-based chemotherapy (P = 0.005) were identified as independent risk factors for shorter survival. To establish a new therapeutic strategy for initially unresectable liver metastasis of colorectal cancer, HLNs should be examined histologically in patients undergoing resection of hepatic lesions when they are rendered resectable by effective chemotherapy.
机译:回顾性分析了1997年3月至2007年8月间行原发肿瘤切除术并进行HLN病理组织学评估的43例不能切除的结直肠癌同步性肝转移患者的肝淋巴结转移的频率和意义。 12例(27.9%)。 HLN转移的存在与所检查的12种临床病理因素中的任何一项之间均未发现显着相关性。使用Cox比例风险模型进行多变量分析时,存在HLN转移(P = 0.002),以及大量(>或= 4)区域淋巴结转移(P = 0.003),并且不使用基于奥沙利铂的化疗(P = 0.005)被确定为生存期较短的独立危险因素。为了建立一种针对大肠癌最初无法切除的肝转移的新治疗策略,当通过有效的化学疗法将其切除后,肝切除的患者应从组织学上检查HLN。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号